Positively Positive - Living with HIV/AIDS:
HIV/AIDS News Archive - May 2012
Fifth Annual Celebrity Dim Sum
May 31, 2012 - AIDS Vancouver hosts the 5th Annual Celebrity Dim Sum Event, proudly presented by Caya powered by TELUS , at Sun Sui Wah Seafood Restaurant. This is a unique culinary
experience where guests get to mingle with local Vancouver celebrities while enjoying delicious Dim Sum. Fred Lee and Sophie Lui will once again emcee this entertaining and exciting benefit for the AIDS Vancouver Asian Community Outreach Project.
WHO guidelines encourage couples HIV testing and counselling and use of antiretroviral treatment for prevention
31 May 2012 - In Canada, an estimated 83% of new HIV infections in 2008 occurred through sexual transmission, either
among men who have sex with men (47%) or heterosexual men and women (36%). Among both groups a large number of these sexual HIV transmissions likely took place in the context of intimate relationships.
HIV Infections in US Disproportionately Impact Communities of Color and the Poor
WASHINGTON, DC (May 31, 2012) - HIV Specialists Meet to Identify, Help Those Who Are Falling Through the Cracks
With mounting evidence that many Americans remain the invisible people with HIV/AIDS who live in poverty, have limited health literacy, are diagnosed late in the course of their disease,
and therefore, are the most likely to die of AIDS, leading members of the HIV/AIDS community called for a new mobilization to find, test and treat those people with HIV who are falling through the cracks of the healthcare system.
BioChip may make diagnosis of leukemia and HIV faster, cheaper
May 30, 2012 - UNIVERSITY PARK, Pa. - Inexpensive, portable devices that can rapidly screen cells for leukemia or HIV may soon be possible thanks to a chip that can produce three-dimensional focusing of a stream of cells, according to researchers.
IAVI Welcomes Louis Schwartz as Chief Financial Officer
NEW YORK, May 30, 2012 - The International AIDS Vaccine Initiative (IAVI) is pleased to announce the appointment of Louis Schwartz
as Chief Financial Officer. In this role, Schwartz will oversee the financial operations of the organization, working closely with IAVI's Senior Management Team and Board of Directors.
Dr. Peter on Long Beach
May 30, 2012 - If you lived in BC and watched the CBC news during the 1980s, you will likely remember "Dr. Peter." Dr. Peter Jepson-Young put a face to the disease the general
public was only beginning to learn about: HIV-AIDS. Once a week for about two years, Dr. Peter shared a video diary, updating viewers on his life, his health, and the progression of his disease.
Elton John AIDS Foundation Gives Away $850K 1st Round for 2012
May 30, 2012 - The Elton John AIDS Foundation just announced its first round of donations for 2012. EJAF is the most organized and hands on of the all the AIDS groups, with lots of transparency and very little over head or calling of attention to itself.
In this round, they gave $700,000 to AIDS United (formerly the National AIDS Fund), 100,000 to the Names Project (Quilt in the Capital), and $50,000 to the SERO Project, HIV is not a crime.
Virus Victors: People Who Control HIV
May 29, 2012 - Bruce Walker, professor of medicine at Harvard Medical School and director of the Ragon Institute of Massachusetts General Hospital, M.I.T. and
Harvard, talks about his article in the July issue of Scientific American magazine called "Controlling HIV," about rare individuals who never develop AIDS after being infected by the virus
Listen to Podcast...
First Human Study of HIV Vaccine Vacc-C5 to begin
Oslo 29.05.2012 - Animal Studies Indicate Similar Generation of Immune Responses as Those in HIV Patients who Naturally Suppress the Infection
Bionor Pharma announced today that the first study of Bionor Pharma's Vacc-C5 is now approved to begin at Oslo University Hospital.
Vacc-C5 is a therapeutic HIV vaccine developed to slow down or stop induction of immune hyperactivation, a feature that drives the production of HIV and is damaging the immune system, leading to AIDS.
Vacc-C5 also may have the potential to be a preventive vaccine, alone or in combination with Vacc-4x.
NIH Scientists Identify New HIV-Inhibiting Protein
May 29, 2012 - Potential Role in HIV Treatment and Prevention under Study
WHAT: Scientists have identified a new HIV-suppressing protein in the blood of people infected with the virus.
In laboratory studies, the protein, called CXCL4 or PF-4, binds to HIV such that it cannot attach to or enter a human cell. The research was led by
Paolo Lusso, M.D., Ph.D., chief of the Section of Viral Pathogenesis in the Laboratory of Immunoregulation at the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH.
UNAIDS highlights Zimbabwe's progress in responding to AIDS
28 May 2012 - UNAIDS Executive Director Michel Sidibé concluded his first official visit to Zimbabwe on 25 May after
meeting with President Robert Mugabe and Prime Minister Morgan R. Tsvangirai to highlight the country's progress in the AIDS response.
The Positive Side
Summer 2012: Art for our sake
The Positive Side commemorates 30+ years since the start of the HIV epidemic with our cover story which delves into the dynamic relationship between art and AIDS. We present four Canadian artists whose works reflect the realities of living with the virus and help shape our understanding of HIV/AIDS.
Jason Kenney's cuts to the Interim Federal Health Program will hurt refugees living with HIV and viral Hepatitis co-infection
TORONTO, May 25, 2012 - On July 1st, the Conservative Harper government will be celebrating Canada Day by slashing the
Interim Federal Health Program (IFHP) - a program that provides supplemental health benefits for refugee claimants.
Starting HIV treatment with a CD4 cell count below 350 associated with a key marker of cardiovascular risk
25 May 2012 - Starting HIV treatment with a CD4 cell count below 350 cells/mm3 may increase the long-term risk of cardiovascular disease,
US research published in AIDS suggests. Investigators found that men who started therapy with a CD4 cell count below
this threshold had much poorer endothelial function, a key measure of vascular health, than individuals who started treatment when their CD4 cell count was above 350 cells/mm3.
The ISHEID Meeting Makes a Donation of 2,500 Euros to The Berlin Patient, The First Man Cured from HIV/AIDS
May 25, 2012 - Marseilles, France - The International Symposium on HIV & Emerging Infectious Diseases (ISHEID) currently held in
Marseilles, France, is focused on a search for an HIV cure. Timothy Ray Brown, the "Berlin Patient" is the main star of it.
HIV infection currently hits 34 millions individuals worldwide. It is therefore a top priority to find a vaccine for those who have not yet been
infected and a cure for those who already are.
High rates of hospitalization among HIV-positive people in Winnipeg
24 May 2012 - Researchers in Winnipeg, Manitoba, have reported that some people in that city are finding out that they are
HIV positive late in the course of this infection. In a 2010 report, nearly 50% of people had their first HIV-positive test result when they sought care for a life-threatening infection.
UNAIDS and PEPFAR bring together Health Ministers and partners to advance progress in ending new HIV infections in children
23 May 2012 - Ministers of Health and representatives from the 22* countries with the most new HIV infections in children have come
together to report on progress towards achieving zero new HIV infections in children by 2015 and find ways of stepping up action.
Chevron Fights HIV/AIDS in South Africa
May 22, 2012 - In the Dunoon community near Chevron's Cape Town Refinery, more than 50 percent of residents have HIV/AIDS.
New Video: Staying HIV Neg Gets Tough, Health Departments Dancing Around, Miami Gay Matchmaker Speaks Out about the Dangers: 45% of "Certain" Gays Are HIV Poz
May 22, 2012 - Miami - New research by Paul Angelo MHA, MBA, gay matchmaker from Miami reveals staggering new statistics for Fort Lauderdale and Miami gay men.
Antiretroviral therapy may be stabilising HIV epidemic in Danish gay men
May 22, 2012 - The use of antiretroviral treatment appears to have stabilised the HIV epidemic in Danish gay men, even though rates of risky sex have increased, research published in the online edition of the Journal of Acquired Immune Deficiency Syndromes suggests.
Newly discovered breast milk antibodies help neutralize HIV
22-May-2012 - Antibodies that help to stop the HIV virus have been found in breast milk. Researchers at
Duke University Medical Center isolated the antibodies from immune cells called B cells in the breast milk of infected mothers in Malawi, and showed that the B cells in breast milk can generate neutralizing antibodies that may inhibit the virus that causes AIDS.
HIV Vaccine Trials Network Opens Enrollment for Phase 1 Trial of GeoVax Labs' Second Generation HIV Vaccine
ATLANTA - May 22, 2012 - Total of 48 Subjects To Be Enrolled at Four Sites Across U.S.
The HVTN 094 trial will enroll a total of 40 vaccinated and 8 control/placebo subjects to be studied at four sites nationwide: the University of Alabama
at Birmingham; Brigham and Women's Hospital, Boston; the University of Rochester, and the San Francisco Department of Public Health.
When bad science kills, or how to spread AIDS
May 22, 2012 - A fatal irony: Why the "circumcision solution" to the AIDS epidemic in Africa will increase transmission of HIV
The Morning After
Talking about HIV is hard...
Having HIV is even harder
Talk with all your sex partners about HIV.
If you don't know your staus, get tested.
HIV is still a big deal
Josh is a 26 year old gay man in New York City. This is his story.
Vancouver International AIDS Candlelight Memorial - May 20th 2012
May 22, 2012 - VANCOUVER, BC: - AIDS Vancouver, along with 16 partner agencies, held a beautiful and solemn AIDS Candlelight Memorial on Sunday, May 20, 2012,
with over 60 people attending the event in spite of the rainy weather.
This was the 29th Vancouver International AIDS Candlelight Memorial and the theme is "Promoting Health and Dignity Together". The International coalition of 1,200 community organizations in 115 countries,
all aim to raise awareness around HIV and to promote respect for the human rights of people living with HIV everywhere.
4TH SYMPOSIUM ON HIV, LAW AND HUMAN RIGHTS
June 14, 2011
Hosted by the Canadian HIV/AIDS Legal Network.
This year's Symposium is being held in conjunction with the Canadian AIDS Society PLWHIV/AIDS Forum and the AGMs of CATIE and the Canadian Working Group on HIV and Rehabilitation (CWGHR).
UNAIDS joins 20th Anniversary Life Ball in Vienna
21 May 2012 - Europe's biggest AIDS charity event was held on 19 May in the Austrian city of Vienna. Organized by AIDS LIFE, the Life Ball 2012
brought together celebrities and influential leaders in the global AIDS response to celebrate the 20th anniversary of what has become one of the largest AIDS fundraising events worldwide since it was first held in 1993.
Living with HIV and Hepatitis C Co-infection
20 May 2012 - This new booklet is written for people living with HIV and hepatitis C co-infection. It
guides readers through a range of issues, from the effects of co-infection and treatment strategies to preventing transmission.
CELEBRITY DIM SUM
Proudly presented by caya powered by TELUS
June 2, 2012 - 11AM - 1 PM
SUN SUI WAH SEAFOOD RESTAURANT
3888 Main Street, Vancouver BC V5V 3N9
A benefit to support the AIDS Vancouver Asian Community Outreach Project
100000 expected for AIDS memorial
May 19, 2012 - Around 100,000 people worldwide are expected to commemorate the International AIDS Candlelight Memorial
Sunday to remember those who have lost their lives to AIDS and to support those living with HIV and affected by its impact. Supported by community, business and religious leaders in 500 town and villages in 115 countries, Memorial participants call for greater action from all actors in the HIV response.
HIV infections are being missed in UK patients with suspected glandular fever
18 May 2012 - HIV infections in patients with suspected glandular fever are often missed, investigators from south London report in HIV Medicine.
OraSure Technologies Applauds CDC Proposed Draft Guidelines for Testing of Baby Boomers for Hepatitis C
BETHLEHEM, Pa., May 18, 2012 (GLOBE NEWSWIRE) - Draft Recommendations Call for HCV Testing of All Persons Born Between 1945 and 1965
today issued a statement in strong support of the Center for Disease Control and Prevention (CDC) draft guidelines proposing that all U.S. baby boomers get a one-time test for the hepatitis C virus (HCV).
OraSure Technologies Announces Rapid HCV Testing Initiatives for First National Hepatitis Testing Day
BETHLEHEM, Pa., May 18, 2012 (GLOBE NEWSWIRE) - OraQuick(R) HCV Tests to be Deployed in New York City Department of Health "Check Hep C NYC" Campaign
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced its support of numerous rapid hepatitis C (HCV) testing initiatives for the first National Hepatitis Testing Day, taking place on May 19, 2012.
CDC Announces First Ever National Hepatitis Testing Day and Proposes that All Baby Boomers Be Tested Once for Hepatitis C
May 18, 2012 - On the eve of the first ever National Hepatitis Testing Day (May 19), the Centers for Disease Control and Prevention is issuing draft guidelines
proposing that all U.S. baby boomers get a one-time test for the hepatitis C virus.
HIV Vaccine Awareness Day
May 18, 2012 - Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health
There is a growing consensus that we can significantly curtail the HIV/AIDS pandemic by implementing scientifically proven HIV prevention strategies, such as voluntary medically supervised adult male circumcision, prevention of mother-to-child transmission and treatment as prevention.
Pelosi Statement on Mayor Lee's Restoration of Funding for HIV/AIDS Care, Treatment, and Prevention
May 17, 2012 - Washington, D.C. - Democratic Leader Nancy Pelosi released the following statement today after
San Francisco Mayor Ed Lee announced that the City of San Francisco would restore $6.6 million for HIV/AIDS care, treatment and prevention funding for FY 2012-13.
Transgender persons are "Lost in Transition" on Human Rights and HIV Responses says new Asia-Pacific Report
Bangkok, 17 May 2012 - A lack of targeted research on transgender persons in Asia and the Pacific is significantly
hindering their access to health services and blocking effective responses to HIV, says a groundbreaking study released here today to mark the International Day Against Homophobia and Transphobia.
Should hiding HIV status always be a crime?
May 17, 2012 - (CBS/AP) - Canadians living with HIV should not face jail time for keeping their medical condition from sexual partners if the risk of transmission is low or if they use condoms while having sex, civil liberties advocates say.
A Changing Landscape in Fighting AIDS
WASHINGTON, May 17, 2012 - Scientist and Community Leaders Look Ahead in 2012
This summer, more than 25,000 leading scientists, public health experts, policy-makers, community members, and experts in the HIV/AIDS field from around the world will gather
in our nation's capital for the International AIDS Society's XIX International AIDS Conference. This gathering provides a vital platform to address the global response to HIV/AIDS and the efforts
to overcome barriers that limit access to care, services, prevention tools, and research.
New Civil Society Partner for AIDS 2014 and AIDS 2016
- Positive Women's Network, South Africa -
16 May 2012 - On behalf of the International AIDS Conference permanent partners, the International AIDS Society (IAS)
would like to welcome Positive Women's Network, South Africa to be the new civil society partner for AIDS 2014 and AIDS 2016.
NAPWA salutes FDA Advisory Committee for recommending approval of OTC home HIV test
(Washington, D.C., May 16, 2012) - NAPWA salutes FDA Advisory Committee for recommending approval of OTC home HIV test, urges public education about
implications of both positive and negative test results
With an estimated one-fifth of Americans who live with HIV unaware they are infected, there is an obvious need for more testing and more ways to get tested.
Reduced glycerin formulation of tenofovir vaginal gel safe for rectal use
Redondo Beach, CA (PRWEB) May 16, 2012 - Reformulated gel could serve as an anti-HIV product for both vagina and rectum
A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a
study published online this week in the Journal of Antimicrobial Chemotherapy.
AIDS survivors are encouraged to come out of the closet to help raise awareness and eradicate STIGMA.
Redondo Beach, CA (PRWEB) May 16, 2012 - In his memoir, "Out of My Second Closet: I Have AIDS-Get OVA It!", Author, Dwayne Carl, former corporate executive, encourages
other AIDS victims to speak out in order to weaken the grip that silence imposes on efforts at prevention, treatment and research.
HIV may afflict almost half Asia-Pacific transgenders: UN
May 16, 2012 - Nearly half of transgender people in the Asia-Pacific region could have HIV as poor healthcare and
high-risk lifestyles push infection rates to "critical levels", a UN report said Thursday.
FilmOut: Q&A with Austin Head, co-star of "Positive Youth" documentary | VIDEOS
May 16th, 2012 - Austin Head, aka the "Glamour Boy of Phoenix," is one of four HIV-positive youth featured in the 44-minute documentary "Positive Youth."
HIV/AIDS drugs too expensive, expert says
May. 15, 2012 - HIV/AIDS drugs are not affordable, Mohammad Akhter, a former executive director of the American Public Health Association, tells a U.S. Senate Subcommittee hearing
Anti-HIV drug tenofovir is safe to take during pregnancy
15-May-2012 - Pre-birth exposure to the anti-HIV drug tenofovir does not adversely affect pregnancy outcomes and does
not increase birth defects, growth abnormalities, or kidney problems in infants born to African women who are HIV positive, supporting the use of this drug during pregnancy, according to a study by a team of international researchers published in this week's PLoS Medicine.
MEDIA ADVISORY: 27th ANNUAL AIDS WALK NEW YORK
WHAT: 27th annual AIDS Walk New York (AWNY)
WHEN: Sunday, May 20, 2012
More than 45,000 participants are expected to attend. The landmark event benefits GMHC and 41 other local AIDS service organizations who provide food, housing, medical care, and much more to people
living with HIV/AIDS, as well as vital prevention work that reaches hundreds of thousands throughout the tri-state area.
Are people with HIV/AIDS more prone to sudden cardiac death?
14-May-2012 - Groundbreaking 10-year UCSF research examines causes of death among HIV patients in San Francisco
What is the connection, if any, between sudden cardiac death and people with HIV/AIDS? And can that knowledge help prolong their lives?
THE PARSONS FOUNDATION GIVES $5MM TO FIGHT HIV/AIDS
SCOTTSDALE, Ariz. (May 14, 2012) - Southwest Center to Build Parsons Foundation Center for Health, Education & Wellness
The Parsons Foundation is making a multi-million dollar contribution to help men, women and children battling HIV/AIDS in Arizona. The Southwest Center for HIV/AIDS announced
a combined donation of $5 million from the founders of The Parsons Foundation , Renee and Bob Parsons.
The Connection Between Sudden Cardiac Death and People with HIV/AIDS
May 14, 2012 - In a comprehensive, 10-year UCSF study, researchers found patients with HIV/AIDS suffered sudden cardiac death at
a rate four times higher than the general population.
Beyond Belief, a captivating story about living with HIV/AIDS, opens in New York City June 22, 2012.
PRLog (Press Release) - May 13, 2012 - Beyond Belief is a brand new stage production about the life of Daniel Bauer, the successor to Harry Houdini,
and his personal experiences living with HIV/AIDS. Previews are June 22-23 at CAP21 located at 18 W. 18th Street, 5th Floor, New York City.
HIV prevention measures must include behavioral strategies to work, says APA
14-May-2012 - WASHINGTON - Truvada alone not sufficient, given adherence and other challenges
A drug that has been shown to prevent HIV infection in a significant number of cases must be combined with behavioral approaches if the U.S.
health care establishment is to succeed in reducing the spread of the virus, according to the American Psychological Association.
U.S. sheds the Helms Rule's legacy
May 13, 2012 - This July, a shadow that Jesse Helms cast over HIV policy will be dramatically lifted.
The enormous International AIDS Conference will meet in the United States for the first time in more than 20 years, ending a boycott that protested a policy the late North Carolina Republican senator pushed into law.
HIV bill is wrong
May 13, 2012 - There is no medical basis for B.C. Labour and Citizens' Services Minister Margaret MacDiarmid's Bill 39, which contributes to misinformation and stigmatization of those living with HIV/AIDS.
THE BANYAN TREE PROJECT LAUNCHES NATIONAL DIGITAL STORYTELLING CAMPAIGN TO END HIV STIGMA FOR ASIANS, PACIFIC ISLANDERS
May 11, 2012 - COMMUNITIES MOBILIZE IN HONOR OF NATIONAL ASIAN & PACIFIC ISLANDER HIV/AIDS AWARENESS DAY
May 19th, 2012 is the 8th annual National Asian & Pacific Islander HIV/AIDS Awareness Day. To commemorate the day, the Banyan Tree Project is launching a community-driven
initiative to end HIV stigma and discrimination among Asian Americans, Native Hawaiians, and Pacific Islanders (AAs and NHPIs). "Taking Root: Our Stories, Our Community" is an innovative digital
storytelling project produced in partnership with the Center for Digital Storytelling.
Insights: Using Truvada to Prevent HIV Infection
May 10, 2012 - Rodney Wright, M.D., assistant professor of obstetrics & gynecology and women's health at Albert Einstein College of Medicine of Yeshiva University
and director of HIV programs in the department of obstetrics and gynecology at Montefiore Medical Center, discusses this new use of Truvada -- both its benefits and potential hazards.
HIV-prevention pill endorsed by U.S. health officials
May 10, 2012 - Food and Drug Administration backs Truvada tablet for those at risk of infection
In a series of votes, a Food and Drug Administration advisory panel recommended approval of the daily pill Truvada for healthy people who are at high risk of contracting HIV, including gay and
bisexual men and heterosexual couples with one HIV-positive partner.
IAVI, GlycoMimetics, and Glycosensors and Diagnostics Collaborate to Develop Novel AIDS Vaccine Candidate
NEW YORK, NY, GAITHERSBURG, MD, and ATHENS, GA, May 9, 2012 - The International AIDS Vaccine Initiative (IAVI), GlycoMimetics, Inc. (GMI), and Glycosensors
and Diagnostics, LLC (G&D) today announced a collaboration to develop an AIDS vaccine using novel compounds that mimic carbohydrates, called glycomimetics. The project will be funded by IAVI's
Innovation Fund, a program launched to support the application of novel and unconventional technologies to AIDS vaccine design and development.
Truvada for HIV Prevention: FDA Review Is Favorable
May 9, 2012 - A pill that has long been used to treat HIV has moved
one step closer to becoming the first drug approved to prevent healthy people from becoming infected with the virus that causes AIDS.
Acclaimed AIDS Documentary Nominated For Emmy Award
May 9, 2012 - TV documentary 30 Years From Here, a New York-centric look at three decades of the AIDS epidemic, has been nominated for a Daytime Emmy Award as Outstanding Special Class Special.
UNAIDS launches "Believe it. Do it." action campaign to help end new HIV infections among children by 2015
GENEVA, 8 May 2012 - The Joint United Nations Programme on HIV/AIDS (UNAIDS) today launched a new campaign, "Believe it. Do it.", aimed
at bringing attention and action to the global goal of ending new HIV infections among children by 2015 and ensuring mothers living with HIV remain healthy.
A WOK around Chinatown
A Cuinary and Cultural Walking Tour of Vancouver's Chinatown
Suits Dinner - May 28th 5.30 -
Tour and Dinner in Chinatown with Bob Sung
Tour Start Time: 5:30pm - Location: Chinese Cultural Centre Courtyard 50 East Pender Street, Vancouver.
Started in January 2009, the SUITS POZ GAY WORKING MEN'S DINNER GROUP began in response to a need
for a support program for HIV-positive working men.
A Photographic Exploration of Housing and Health
05-8-12 - Written by Surita Parashar
There are little systematic data available on the socioeconomic needs of Persons Living With HIV/AIDS (PHA) in BC, therefore the impact of housing instability on
the health outcomes of this population is not fully understood in this context. Findings from the BC Centre for Excellence in HIV/AIDS-based Longitudinal Investigations into Supportive and
Ancillary Health Services (LISA) study suggest that 32% of people accessing antiretroviral therapy in BC are unstably housed. Of those, 83% live in, or frequent, the city of Vancouver.
HIV & the Brain
The Latest Evidence on HIV-Associated Neurocognitive Disorders (HAND)
Community Forum: HIV & the Brain
When: Tuesday May 22, 2012.
Event Time: 6 to 8 PM
Where: Chateau Granville 1100 Granville St, Vancouver, BC
5th Annual Celebrity Dim Sum
May 8, 2012 - VANCOUVER, BC - AIDS Vancouver presents the 5th Annual Celebrity Dim Sum Event, generously sponsored by Caya powered by TELUS, at Sun Sui Wah Seafood Restaurant. This is a unique culinary experience where guests get to mingle with local
Vancouver celebrities while enjoying delicious Dim Sum. Fred Lee and Sophie Lui will once again emcee this entertaining and exciting benefit for the AIDS Vancouver Asian Community Outreach Project.
When: June 2nd, 2012.
Event Time: 11am to 1:30pm
Where: Sun Sui Wah Seafood Restaurant, 3888 Main Street, Vancouver
Believe it. Do it.
Celebrities including Naomi Watts, Whoopi Goldberg and Annie Lennox join UNAIDS in its new "Believe it. Do it." campaign aimed at preventing new HIV infections in children by 2015.
Study confirms early elevated HIV infection risk in some step study participants who received vaccine; risk decreased over time
SEATTLE - May 7, 2012 - After about 18 months, risk level decreased to that of volunteers who received a placebo
A long-term follow-up analysis of participants in the Step Study, an international HIV-vaccine trial, has confirmed that certain subgroups of
male study participants were at higher risk of becoming infected after receiving the experimental vaccine compared to those who received a placebo. The vaccine used in
the study did not contain the HIV virus, but it did contain HIV genes which were delivered to cells using a vector that employed a type of cold virus known as adenovirus serotype 5 (Ad5).
MY DEFINING MOMENT: Dr. Julio Montaner
The Director of the BC Centre for Excellence in HIV/AIDS recounts a defining moment in Vancouver's efforts to combat a major health epidemic.
Vancouver International AIDS Candlelight Memorial
May 5, 2012 - Promoting Health and Dignity Together
AIDS Vancouver is proud to announce the Vancouver International AIDS Candlelight Memorial
Join Us @ 8:00 PM
May 20, 2012
1755 Beach Avenue
Vancouver BC, Canada.
Return of the Clap
May 4, 2012 - Gonorrhea, once a minor illness, is developing resistance to the last category of drugs that still works against it and could become untreatable
Johns Hopkins Establishes New Center for AIDS Research
May 4, 2012 - Johns Hopkins University has been awarded $15 million over the next five years from the National Institutes of Health to establish the new Center for AIDS Research (CFAR).
CFAR will support more than 180 HIV investigators from the University's Bloomberg School
of Public Health, the School of Medicine, the School of Nursing and other schools. A major priority for CFAR will be to address Baltimore's HIV epidemic in addition to training new investigators and conducting international research.
Shape the HIV response: E-survey LIVING 2012 - The Positive Leadership Summit
May 4, 2012 - GNP+ and the LIVING 2012 partnership have launched an electronic survey for people living with HIV to provide input into LIVING 2012: The Positive Leadership Summit.
All people living with HIV worldwide are invited to provide input into the survey and help to shape the HIV response.
"See to understand": Human rights, zero discrimination and improved AIDS response
03 May 2012 - In Guatemala, wearing a pair of red glasses has transcended from being a fashion statement to
a symbol against stigma and discrimination faced by people living with HIV. UNAIDS, in partnership with the National Red Cross, launched "See to understand", a campaign that challenges people to look at the world through
red glasses for a new perspective on what it can mean to live with HIV.
Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argosīs ArcelisT Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
May 4, 2012 - Argos Therapeutics Inc. today announced that study results demonstrated that analytical
treatment interruption to assess the antiviral activity of Argosīs ArcelisT personalized immunotherapy for the treatment of HIV patients,
AGS-004, is an acceptable strategy for at least 16 weeks. Study results were published in the Journal of Medical Virology (84:885-889, 2012).
Napo Comments on FDA Announcing Extension of Crofelemer NDA Priority Review
May 3, 2012 - Napo Pharmaceuticals, Inc. (Napo) has been informed that the U.S. Food & Drug Administration (FDA) has extended the Prescription Drug
User Fee Act (PDUFA) date for the company's first in class novel drug compound, crofelemer. The Agency's Priority Review of the New Drug Application (NDA) for crofelemer is for the indication
of chronic diarrhea in people living with HIV/AIDS who are on anti retroviral therapy.
Jamar Rogers - After his Elimination
May 3, 2012 - by POZ I AM RADIO
This Friday May 4th at 12pm EST the POZ I AM Radio show hosts Robert Breining and Jack Mackenroth will be speaking with Jamar Rogers about his time as a contestant on The Voice.
Liver transplants in HIV-HCV co-infection-results from a U.S. study
3 May 2012 - The NIH study has yielded important information that could be used by transplant teams to improve the survival
of HIV-HCV-infected people who need a liver transplant.
The need for liver transplant in HIV-HCV co-infection
2 May 2012 - Although deaths from AIDS-related infections have greatly decreased in high-income countries, serious illness
and death from complications of hepatitis C virus (HCV) infection are rising among HIV-positive people.
Only 20% of US HIV-positive people have high levels of engagement with specialist HIV care
02 May 2012 - Only a fifth of HIV-positive people in the United States are fully engaging in specialist HIV care, research published in the online edition of the
Journal of Acquired Immune Deficiency Syndromes shows.
Study finds HIV/AIDS funding does not undermine health care services for other diseases
Deerfield, Ill. (May 2, 2012) - Study addresses long-standing debate about funding imbalances for global diseases
While the battle against HIV/AIDS attracts more donor funding globally than all other diseases combined, it has not diverted attention from fighting
unrelated afflictions -- such as malaria, measles and malnutrition -- and may be improving health services overall in targeted countries, according to a study on Rwanda
published today in the May 2012 edition of the American Journal of Tropical Medicine and Hygiene.
HIV/AIDS: New book tracks the epidemic to its origins
MBABANE, 2 May 2012 (PlusNews) - We've all heard the myths and hypotheses about the origins of the epidemic caused by the HI virus, but a new book, "Tinderbox: How the West Sparked the AIDS Epidemic and How the World Can Finally Overcome It",
sheds more light on where it all began. It is a fascinating account of the medical detective work that traced the disease to Cameroon a century ago.
Genetically Modified T Cell Therapy Shown to be Safe, Lasting in Decade-Long Penn Medicine Study of HIV Patients
May 2, 2012 - PHILADELPHIA - Results Open Up Field of T Cell Gene Therapy for Use in Other Diseases
HIV patients treated with genetically modified T cells remain healthy up to 11 years after initial therapy, researchers
from the Perelman School of Medicine at the University of Pennsylvania report
in the new issue of Science Translational Medicine.
Study using stem cell therapy shows promise in fight against HIV
May 1, 2012 - (SACRAMENTO, Calif.) - UC Davis Health System researchers are a step closer to launching human clinical trials
involving the use of an innovative stem cell therapy to fight the virus that causes AIDS.
Leading AIDS Advocates Support FDA Approval of Pre-Exposure Prophylaxis (PrEP), a Promising New HIV Prevention Method, for Men and Women
May 1, 2012 - New York, NY, - In public comments submitted this week, a group of 14 leading HIV/AIDS and health organizations stated their support
for Food and Drug Administration (FDA) approval of emtricitabine/ tenofovir disoproxil fumarate (TDF/FTC or Truvada) as pre-exposure prophylaxis (PrEP) to prevent HIV infection in adult men
and women. Their comments, submitted in advance of a May 10 FDA Advisory Committee meeting, pointed to compelling evidence on the efficacy of TDF/FTC as PrEP and highlighted the unique
potential of this intervention to help slow the HIV epidemic in the US.
Reclast Boosts Bone Density for at Least Five Years in HIV Study
May 1, 2012 - Results Open Up Field of T Cell Gene Therapy for Use in Other DiseasesTwo annual doses of Reclast (zoledronate) improved bone health for up five years in a small study involving HIV-positive people with bone mineral deficiency, according to
a study to be published by New Zealand researchers in the June issue of The Journal of Clinical Endocrinology & Metabolism (JCEM).
Unmet basic subsistence needs is the most important factor affecting health of poor HIV-positive men
May 1, 2012 - An inability to provide for the most basic needs of life is the biggest predictor of poor physical and mental
health for homeless and marginally housed HIV-positive men, according to a study conducted in San Francisco and published in the open-access journal PLoS One.
International workshop highlights B.C.'s pioneering role in the fight against HIV/AIDS
May 1, 2012 - B.C. leads in the implementation of Treatment as Prevention to significantly decrease death, disease progression, and new HIV diagnoses in the province
Hundreds of leading international HIV scientists from around the world congregated in Vancouver last month to hear the latest research on HIV prevention at the 2nd International HIV Treatment as Prevention Workshop.